Breaking News

BASF Announces Up to 20% Price Increase for Excipients and APIs

Cites rising global energy and raw material costs.

Author Image

By: Charlie Sternberg

Associate Editor

BASF Pharma Solutions has announced a global price increase for certain pharmaceutical excipients and selected active pharmaceutical ingredients (APIs), citing higher global energy and raw material costs. According to the company, prices will rise by up to 20%, with increases taking effect immediately or as permitted under existing customer contracts. The adjustment applies to products supplied across BASF Pharma Solutions’ portfolio worldwide. BASF said the pricing change is intended to s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics